Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches

Sep.15.2025
Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches
BAT Italy will expand its Trieste plant, adding 16 new production lines for heated tobacco cartridges, nicotine pouches, and nicotine replacement therapy products. The expansion adds 6,300 m² of space, bringing the total to 30,000 m². This is part of BAT’s €500 million five-year investment plan launched in 2023.

Key Points:

 

·Expansion and Recruitment: BAT Italy is adding 16 new production lines at its Trieste production site and plans to hire 150 professionals by 2026.

·Product Positioning: The new production lines will focus on new nicotine products, including heated tobacco cartridges (for the Italian market only), while also expanding production capacity for oral nicotine pouches (sold to 16 European countries) and nicotine replacement therapy (NRT) products.

·Site Expansion: A new 6,300 square meters of production area will be added, and the expanded recycling warehouse will bring the total area to 30,000 square meters, tripling the original planned area.

·Employment and Positions: The project is part of BAT Italy's five-year plan announced in 2024 and is expected to create 2,700 jobs, primarily in manufacturing and engineering.

·Investment Background: The expansion is part of a five-year €500 million investment plan launched in 2023. By 2024, BAT had invested 168 million euros in Italy, created an output value of 30 million euros, and made a profit of 1.6 million euros, all of which had been reinvested in development.

 


 

2Firsts, September 15, 2025 - According to reports from ticonsiglio and ilsole24ore, British American Tobacco (BAT) Italy plans to hire 150 new positions at its Trieste production site through expansion and the introduction of new production lines.

 

BAT Italy has added 16 production lines to the site and expects to complete the recruitment of 150 professionals by 2026.

 

The expansion will be entirely dedicated to the production of new nicotine products, including heated tobacco cartridges, which users can use with specialized heated tobacco devices. These products will be sold exclusively in Italy.

 

These new production lines will also join existing lines for the production of oral nicotine pouches (currently sold in Italy and 15 other European countries) and the recently commissioned production line for nicotine replacement therapy (NRT) products. The expansion will add an additional 6,300 square meters, including the reuse of a disused warehouse in Trieste's Cargo Village, bringing the total area to 30,000 square meters: triple the original industrial plan's 10,000 square meters.

 

As part of its annual plan, BAT Italy announced in 2024 that it would create 2,700 jobs over the next five years. The majority of these future positions are expected to be in the production and manufacturing sector, encompassing roles such as production operators, equipment maintenance, quality control, technicians, engineers, and production process coordinators.

 

The expansion is part of a five-year, €500 million investment plan launched in 2023. According to data analysis, BAT invested €168 million in 2024 alone, generating €30 million in output. Profits reached €1.6 million in the previous fiscal year, all of which were invested in company development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
Australian Government and Spotify Launch Third Phase of Youth Vaping Education Campaign
The Australian Government and Spotify have launched the third phase of the Youth Vaping Education Campaign under the theme “Buddy Up – Make a Pact to Quit Together.” This phase shifts the focus toward peer and community support by encouraging young people to quit vaping together.
Apr.16 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
China’s e-cigarette export value declined to $694 million in April 2026, marking the lowest April level in the past three years. The data is notable because April was the first full month after China removed export VAT rebates for certain e-cigarette products. Compared with April 2025, export value fell 20.9%; compared with April 2024, it was down 22.3%. Month-on-month, exports dropped 23.2% from March 2026.
Special Report
May.23
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G reports a 27.6% increase in Q1 operating profit, with traditional and new tobacco sectors driving growth.
May.07 by 2FIRSTS.ai
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai